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Summary: The levels of diadenosine tetraphosphate hydrolase, a nucleotide pyrophosphatase (EC 3.6.1.9),
j were measured in human sera with a bioluminescence method. 40 sera of healthy donors and 207 samples
j obtained from inpatients of a medical clinic were analysed. About two thirds of the patients showed increased
l hydrolase levels, äs compared to the normal donors. Elevated levels were not specific for a certain disease,
! and they were found in quite different disorders. There was no indication for a dependency of enzyme
* activity on age or sex of the patients. The comparison of diadenosine tetraphosphate hydrolase with seven
j other laboratory parameters revealed a highly significant correlation with -glutamyl transferase, suggesting
] that the liver may be a source of elevated serum activities. There was evidence that the gastrointestinal tract
j and the pancreas may also be regarded äs possible organ sources of the hydrolase.
| Introduction These dinucleotides have been found in human plate-
, \ Diadenosine tetraphosphate hydrolase is a nucleotide lets in abundant amounts (2, 3). After activation of
< pyrophosphatase (EC 3.6.1.9) which occurs both in the platelets both dinucleotides are released into the
l human plasma and serum. There are no differences surrounding medium (2, 3). Recently a physiological
l of activity between the two body fluids. The enzyme role of APsA and AP4A in the haemostatic process
i has been highly purißed in our laboratory (1). It is a has been claimed. Ap3A has been shown to be an
;|' glycoprotein complex with a relative molecular mass inducer of platelet aggregation, whereas Ap4A in-
'i of about MT =200000. Fof füll enzyme activity hibits this process (4). It is interesting that Ap3A itself
! the hydrolase needs divalent cations. The Substrate does not trigger aggregation. The final trigger is ADP,
specificity is not confined to diadenosine tetraphos- which is generated from Ap3A by the action of the
: phate (Ap4A). The homologue dinucleotide diadeno, nucleotide pyrophosphatase. Variations of its activity
sine triphosphate (Ap3A) is also cleaved yielding ADP maV *>* of significance for processes such äs throm-
| and AMP äs products. Several other nucleotides are bosis and haemostasis.
attacked by the enzyme, but the preferred Substrates Data on the catalytic activity concentration of the
of the pyrophosphatase are the dinucleotides Ap3A enzyme under normal äs well äs under various patho-
and Ap4A (1). logical conditions were hitherto lacking. The possible
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use of the enzyme äs a tool in clinical biochemistry
needs to be evaluated. In this pilot study we have
focussed on inpatients of a medical clinic.
Since we measured enzyme activity in the present
study with a bioluminescence assay, using Ap4A äs a
Substrate, we refer to the enzyme äs diadenosine
tetraphosphate hydrolase. The enzyme, however,
does attack other nucleotides.
Statistics
Mean values and Standard deviations were computed. Gaussian
distribution of the data was tested graphically. The values were
plotted äs a cumulative frequency histqgram on probability
paper. To assess the significance of differences between means
the Studenfs t test or the test of Wilcoxon, Mann & Whitney (in
the case of uüequal variances) was used. Correlations between
different laboratory parameters were ranälysed by calculation
of the coefficients of correlation.
Materials and Methods
Sera
Fourty normal sera were obtained from healthy laboratory
workers or from students. Their age ranged between 20 and 35
years (24 men, 16 women). Pathological sera were obtained
from the University Hospital Erlangen-Nürnberg (medical
clinic). Samples (n = 207) were collected within one month on
four different days. The ratio between males and feinales was
1.5. The patients' age ranged from 19 to 88 years.
Further Information on the patients was available in 182 of the
207 cases. In addition to the diagnosis, we utilized several
laboratory parameters, such äs serum protein, serum albumin,
total bilirubin, amylase (serum), aspartate aminotransferase,
alanine aminotransferase, -glutamyl transferase and lactate
dehydrogenase. These values were taken from the medical
records.
All the sera were stored frozen at — 20 °C. Diadenosine tetra-
phosphate hydrolase activities of the sera were determined
within four weeks after receipt of the samples. There was no
evidence of a loss of enzyme activity during this time.
Determination of diadenosine tetraphosphate hy-
drolase activity in human serum
We have used a slightly modified bioluminescence method
which has already been described in detail (1). In principle,
Ap4A is cleaved by the hydrolase, yielding AMP and ATP äs
products. ATP is detected by the luciferin-luciferase reaction.
The reaction assay contained in a total volume of 0.5 ml:
Ap4A äs a Substrate at l / , 25 mmol/1 Hepes (pH 7.75),
3.8 mmol/1 MgCl2 and 50 of luciferin/luciferase (AMR; from
LKB).
The reaction was started by the addition of 20 or 50 of
serum, which had been diluted 1:10 with Tris-HCl 50 mmol/1
pH 8.0.
The increase of luminescence was monitored with a photomulti-
plier (Lumacounter Model 2080; Lumac Systems AG, Switzer-
land) every 30 seconds (Integration mode). The increase of
bioluminescence during the first niinute after addition of en-
zyme (serum) was taken äs initial velocity.
Since the luminescence of the AMR (per pmol of ATP) de-
creased with prolonged storage at room temperature, a calibra-
tion of the assay was necessary. This was performed by adding
a Standard quantity of ATP (2 pmol) to the reaction mixtüre
described above, but in the absence of Ap4A and serum. Activ-
ity determinations of four sera and one calibration experiment
were run in parallel. The value of one calibration was taken äs
reference value. Ratios of the reference value and the values
obtained from the other calibration experiments were used to
correct the serum enzyme activities.
Results
Diadenosine tetraphosphate hydrolase as-
say
The linear relationship between diadenosine tetra-
phosphate hydrolase activity and the amount of
serum in the assay is deirionstrated in figure 1. Two
sera with different levels of enzyme activity were used.
With both samples the hydrolase activities were linear
up to 9 of serum. For roütine measurements en-
zyme activity was determined with 2 and 5 of
serüm, respectively, both sample volurnes therefore
being within the linear ränge of the te$t. The linear
relationship between the amount of enzyme preserit
in the assay and the induced bioluminescence indi-
cated that quench phenomena played no major role.
The imprecision of the test was evaluated äs follows.
About 80 sera were pooled and stored in small por-
tions at —20 PC. Each deterinination was performed
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Fig. 1. Dependence of the measured catalytic activity eoncen-
trätion of diadenosine tetraphospha.te hydrolase on the
volume of serum used in the assay!
Two different sera were used in this experiment: one
from a healthy donor with a normal enzyme cata.lytic
concentration (open circles) and one serüm obtained
from an inpatient with an increased enizyitie catalytic
concentration (closed circles):
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phate hydrolase activities were measured on seven
days within a period of five months. Five independent
determinations were run per day. The imprecision
(expressed äs Variation coefficients) on the seven days
were 7.9%, 7.5%, 7.4%, 6.8%, 7.5%, 11.6% and
9.6%, respectively. The corresponding mean values
of the hydrolase activities were 117.4, 103.5, 110.9,
105.3, 83.8, 114.0 and 96.2 mU/1 of serum, respec-
tively. The reproducibility from day to day (11%)
was a little worse than the reproducibility on one day
(see above).
There was no evidence of a loss of enzyme activity
during a storage period of 5 months (at —20 °C).
A comparison of enzyme activities in serum and
plasma revealed no differences. Also no differences
were found in slightly haemolytic and non-haemolytic
sera.
Diadenosine tetraphosphate hydrolase ac-
tivities in normal and pathological sera
The activities of 40 healthy volunteers and of 207
inpatients from the local medical clinic were meas-
ured. The results are demonstrated äs a relative fre-
quency histogram in figure 2. The mean values of the
activities of the normal serä and of the pathological
sera were 90.5 ±21.0 (± SD) and 159.1 ± 45.2
(± SD) mU/1 serum, respectively. Plotting of the data
on probability paper revealed a Gausn&n distribution
for both groups. The differences between the mean
activities were highly sigriificant (p < 0.001, test of
Wilcoxon, Mann & Whitney).
Since both groups were heterogenous with respect to
their age we wanted to rule out a possible inflüeüce
of age on the enzyme activity (the age of the normal
donors ranged between 20 and 35 years, the age
of the patients between 19 and 88). Therefore the
reference group was compared only with those
patients under the age of 35. The results did not
change essentially. On the contrary, the difference
between both groups increased slightly (mean ± SD
of the patients: 180.1 ± 37.7 mU/1 of serum, n = 38)
(fig. 3). We then divided the group of inpatients into
three classes of different age. The subgroups were
designated äs A « 45 years), B (46-60 years) and
C (>60 years). The mean enzyme activities in A, B
and C were 179.6 ± 39.1 (± SD, n = 58) 154.6 ±
47.1 (±SD, n = 68) and 145.5 ± 43.8 mU/1 of serum
(±SD, n = 79), respectively. Thus a slight decrease
of the hydrolase activity was observed with increasing
age.
Furthermore there were no differences between males
and females. The mean enzyme activities of the in-
patients were 160.9 ± 48.2 (± SD, n = 124) and
156.1 ± 38.6 mU/1 of serum (± SD, n = 83), respec-
tively. The healthy donors also showed no differences
between the sexes.
When the diadenosine tetraphosphate hydrolase ac-
tivities were compared with the diagnoses (fig. 4)
increased äs well äs normal values were found with
all disorders. Sera showing increased activities pre-
dominated in all groups. Patients with pancreatitis
always had elevated levels of the hydrolase activity.
Diadenosine tetraphosphate hydrolase and
other läboratory parameters
We compared the hydrolase activities in the serum
with several other enzymes and with bilirubin (tab.













38.5 7&9 1<15.4 153. 19Z3 230. 269.2 3077 346.2 384.6
Diadenosine tetraphosphate hydrolase [mU/U
Fig. 2. Frequency histogram of diadenosine tetraphosphate hy-
drolase catalytic activity concentrations in sera of
healthy donors (hatched bars, n = 40) and in sera of
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Fig. 3. Frequency histogram of diadenosine tetraphosphate hy-
drolase activities in sera of donors under the age of
35. Inpatients (open bars, n = 38), healthy volunteers
(hatched bars, n = 40).
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Tab. 1. Comparison between diadenosine tetraphosphate hydrolase and other labpratory parameters.
Diadenosine tetraphosphate hydrolase activities were taken äs increased, when the value was greater than -f 2 SD with
regard to our reference group. The other parameters were evaluated according to the reference values used in the hospital
laboratory.
r = coefficient of correlation, n. s. = not significant, n. d. = not detectable
Parameter Total Number of cases with an in- Correlations with diadenosine
creased level of the paratöeter tetraphosphate hydrölase











































(p < 0.40) n. s.
(p < 0.20) ii. s.
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Fig. 4. Serum diadenosine tetraphosphate hydrolase catalytic
activity concentrations in sera of healthy volunteers and
163 inpatients.
Results from 163 of 207 sera measured for enzyme
catalytic activity concentrations could be related to a
clear diagnosis. The group "heart diseases" mainly con-
sisted of myocardial infarctions, coronary heart diseases
and cardiac insufflciencies. Benign disorders of the lungs
were pneumonia, emphysema and bronchitis. Acute and
chronic myeloid leukaemia, Hodgkm's disease and ma-
lignant lymphomas were subsumed under "neoplasms
of the blood". The group "other dieseases" cbntained
44 cases with 26 different disofders, both of benign and
malignant nature. The dashed lines indicate the mean
± 2 SD ränge of the catalytic concentrations from the
normal donors. For reasons of clarity open and closed
circles were used by turns.
increased levels of the diadenosine tetraphosphate
hydrolase whereas the other values were elevated only
in 26 — 40% of the cases, with the exception of -
glutamyl transferase, which also showed increased
activities in about two thirds of the patients.
Comparison of the correlations between diadenosine
tetraphosphate hydrolase and the seven other para-
meters (tab. 1), revealed small, but statistically signifi-
cant correlations between the hydrolase and alkaline
phosphatase, alänine aminotransferase, and -gluta-
myl transferase. The highest correlation was found
with -glutamyl transferase. Of 117 patients with
increased -glutamyl transferase 63.2% showed in-
creased catalytic concentrations öf the hydrolase.
It is noteworthy, however, that 67.2% of the 61
cases' with normal -glutamyl transferase values also
exhibited elevated activities of the diadenosine tetra-
phosphate hydrolase. Thus many patients with nor-
mal -glutamyl transferase, i. e. no sign of liver dis-
ease or accompanying liver reaction, had increased
catalytic concentrations of the hydrolase. Arialysis of
the diagnoses of this group revealed that 53% suf-
fered from gastrointestinal disorders (benign and ma-
lignant states of the stomach, small intestine and the
colon). In the group of patients with increased levels
of both enzyme activities, diseases of the gastrointes^
tinal tract were only present in 12% of the cases.
This was also true for the group with the constellation
"increased -glutamyl transferase and normal diad-
enosine tetraphosphate hydrolase".
Discussion
Diadenosine tetraphosphate hydrolase is an enzyme
which occurs in human serum and plasma in equally
high amounts. It has been highly purified and par-
tially characterized in our laboratory (1). The puirpose
of this study was to obtain information on tihe hydro-
lase levels in normals; Furtherrnöre about 200 sera
from inpatients of a medical clinic were measured in
order to study the enzyme levels in various pathologi-
cal conditions. Whether the diadenosine tetraphos-
phate hydrolase might be of value äs a diagiiostic
tool in clinical biochemistfy was a further question.
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This study clearly showed that inpatients had signifi-
cantly increased levels of diadenosine tetraphosphate
hydrolase activity äs compared to the reference
group. When relating enzyme activities with the dia-
gnoses of the patients, increased hydrolase levels were
found in quite different disorders. Thus elevation of
the enzyme was not a specific marker for any particu-
lar disorder. At present, this enzyme has no obvious
relevance äs a diagnostic aid.
However, it should be stressed that about 64% of the
patients showed increased values, whereas only 5%
of the healthy donors had increased activity levels.
Increased values of the diadenosine tetraphosphate
hydrolase are not indicative of a specific disease, but
elevated levels might be a general sign of illness. One
should keep in mind that we have investigated a
selected collective, namely typical patients of a medi-
cal clinic.
Nothing is known about the organ source of the
elevated diadenosine tetraphosphate hydrolase levels.
A direct approach to the investigation of organ distri-
bution by measuring the hydrolase activities in hom-
ogenates of various organs would not give unambigu-
ous results, because of the complexity of the Ap4A
degrading activities; i. e. several cytosolic and particu-
late activities seem to coexist in a wide variety of
tissues (9, 10). However, in this regard the present
work may give some hints.
Since various diseases exhibited increased levels of
the hydrolase one may assume that this enzyme is
present in many organs and tissues. However, this
assumption is not essential to the Interpretation. For
example, -glutamyl tränsferase was also increased in
about twp thirds of the cases, and it is known that
this enzyme is almost only increased in diseases and
reactions of the liver (and biliary tract) (5). This is
explained by the fact that many diseases are accom-
paiiied by reactionjs of the liver.
This explanation cpuld also hold true for the diadeno^
sine tetraphosphate hydrolase. The elevations of en-
zyme activity wöuld then be attributable to the liver.
Several of pur results support the hypothesis that the
liver is a source of the hydrolase. When comparing
the diadenosine tetraphpsphate hydrolase with other
laboratory paranpieters the close correlation with -
glutamyl transferase was remarkable. 63.5% of the
sera showing increased catalytic concentration of -
glutamyl transferase also had elevated activities of
the Ap4A hydrolase.
Besides the liver, other organs may act äs a source
of the serum enzyme activity. Ofthose patients show-
ing a normal -glutamyl transferase activity, i. e. with
no indication for liver cell damage (transaminases
were also in the reference ränge), about 67% had
increased levels of the diadenosine tetraphosphate
hydrolase. This points to another organ or tissue
äs a source for increased hydrolase activities. It is
remarkable that the analysis of the diagnoses revealed
that over 50% of these patients suffered from gas-
trointestinal disorders.
Thus the gastrointestinal tract is very likely to be a
further source of increased diadenosine tetraphos-
phate hydrolase activities in various states of disease.
Another candidate is the pancreas. All cases of pan-
creatitis showed elevated hydrolase activity.
We have recently shown that human platelets contain
Ap3A and Ap4A degrading activities (3). However,
since the activities measured in serum and in plasma
were identical, it appeared that platelets did not con-
tribute to the hydrolase activity found in serum.
Human erythrocytes contain a phosphodiesterase ac-
tivity which is strongly inhibited by Zn2+ (11). On
the basis of this property, the erythrocyte enzyme
is not identical with the diadenosine tetraphosphate
hydrolase from serum, since the serum enzyme is
strongly stimulated by Zn2+ (1). Furthermore there
were no differences in enzyme activities between
slightly haemolytic and non-haemolytic sera from the
same donor.
A possible source of the serum diadenosine tetraphos-
phate hydrolase, however, might be the endothelial
lining of blood vessels. An ectoenzyme which cleaves
Ap3A (which is also a Substrate of the serum hydro-
lase) has recently been demonstrated on endothelial
cells of pig aorta (12). We have confirmed and ex-
tended these results by detecting Ap3A and Ap4A
degrading activities ön calf aortic endothelium (un-
published results). The glycoprotein structure of the
serum hydrolase (1) suggests that this enzyme might
originate from the membrane of vascular endothelial
cells.
The variety of organs discussed here äs a source of
increased enzyme activities in the serum stimulates
the questioii of the existence of isoenzymes. In anal-
ogy with enzymes such äs alkaline phosphatase or
lactate dehydrogenase, it is an obvious assumption
that diadenosine tetraphosphate hydrolase also oc-
cürs in multiple molecular forms.
During the purification there were no indications for
the existence of isoenzymes (1), but there are several
possible reasons for this. Firstly, we isolated the en-
zyme from ACD-(acidum citricum/dextrose)-plasma.
Since it is known that nucleotide pyrophosphatases
are dependent on divalent cations for füll activity
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some of the possible isoenzymes may have been inac-
tivated by the complexing agent citrate. Secondly, it
is possible that the Separation techniques used were
not sufficient to give a good resolution of isoenzymes.
Thirdly, the enzyme was purified from plasma of
healthy donors. Isozymes which are only formed
under certain pathological conditions would have
escaped our notice.
It should be mentioned that the highly purified en-
zyme (5000-fold) possessed a 5'-nucleotide phospho^·
diesterase activity (1). These enzymes are known to
exist in different molecular forms in human serum
(6, 7). For example, four activities were found in sera
of healthy persons and under certäin pathological
conditions a fifth isozyme appeared. In a very recent
paper even more activities were detected in the serum
(8). We assume that at least one of the S'-nucleotide
phosphpdiesterases is identical with the diadenosine
tetraphosphate hydrolase. Further research is neces-
sary to find out whether all the phosphodiesterases
can cleave Ap4A and whether there are diadenosine
tetraphosphate hydrpläses withöut any phosphodies-
terase activity.
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